11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - male and female - 1,770 mg/kg (OECD Test Guideline 401)
Inhalation: No data available
LD50 Dermal - Rat - > 500 mg/kg
Remarks: (External MSDS)
Skin corrosion/irritation
Skin - Rabbit
Result: No skin irritation - 4 h (OECD Test Guideline 404)
Serious eye damage/eye irritation
Eyes - Rabbit
Result: Causes serious eye irritation.
(OECD Test Guideline 405)
Respiratory or skin sensitization
- in vitro test
Result: negative
Remarks: (ECHA)
Germ cell mutagenicity
Test Type: In vitro mammalian cell gene mutation test
Test system: mouse lymphoma cells
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 476
Result: negative
Test Type: Ames test
Test system: Salmonella typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Test Type: Chromosome aberration test in vitro
Test system: Human lymphocytes
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 473
Result: negative
Test Type: Micronucleus test
Species: Mouse
Cell type: Bone marrow
Application Route: Gavage
Method: OECD Test Guideline 474
Result: negative
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Repeated dose toxicity - Mouse - male and female - Oral - 52 Weeks - NOAEL (No observed adverse effect level) - 450 mg/kg
Remarks: No significant adverse effects were reported
RTECS: DU1800000
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
After absorption:
Systemic effects: drop in blood pressure tachycardia
Damage to:
Kidney
Liver
Pancreas
Other dangerous properties can not be excluded.
Handle in accordance with good industrial hygiene and safety practice.